Archive for December 2015

Painful Painkillers

Josh Moss Reckitt Benckiser is in the public spotlight after deceiving its customers about the packaging for Nurofen, a drug that relieves pain. According to the ACCC (The Australian Competition and Consumer Commission), the British pharmaceutical firm, Reckitt Benckiser (also known as RB), has made misleading representations on the packaging of each Nurofen Specific Pain…

Read More

The fall of the Rand

James Zackon On the 9th December South African President Jacob Zuma fired Nhlanha Nene, the Minister of Finance, seemingly out of the blue. The reaction in the financial markets was harsh, as over R170 billion ($10.7 billion) was wiped off the value of South African equities, the Rand falling to record lows of 24.34 against…

Read More

What next for Emerging Markets?

David Joseph On Wednesday it came as no surprise that the Federal Reserve increased the deposit rate by 25 basis points. It had been long due, with plans to make the hike earlier in the year scrapped after the Chinese slowdown hit the world’s markets like a sledge hammer following their government’s surprise devaluing of…

Read More

Perrigo acquires Retin-A from Matawan Pharmaceuticals

Christophe Brawand Irish pharmaceutical company Perrigo is acquiring a portfolio of generic forms of Retin-A from Matawan Pharmaceuticals LLC, a subsidiary of generics producer, Rouses Point Pharmaceuticals. The deal was concluded for an undisclosed amount, but will be finalised in Q1 2016, and will be adding more than $0.20 in Perrigo’s adjusted EPS within the…

Read More

Drug development process

Raph Amsili Since the mid-19th century, pharmaceutical industry has had an increasing role in healthcare business. It has become a global phenomenon and governments had had a dual position between supporting research and regulation drug safety and efficacy. For patients, drugs have taken on new medical roles and value. It has become common for people…

Read More